Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency

Denisa Hathazi1, Helen Griffin2, Matthew J Jennings1

  • 1Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge, UK.

The EMBO Journal
|October 31, 2020
PubMed

Insights

Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial myopathy. Digenic inheritance involving mitochondrial DNA and nuclear gene mutations explains disease development and spontaneous recovery in infants.

Area of Science:

  • Genetics
  • Biochemistry
  • Pediatrics

Background:

  • Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial myopathy causing severe infant metabolic issues.
  • The condition is linked to the m.14674T>C mitochondrial DNA mutation, but only a small fraction of carriers develop symptoms, suggesting other factors are involved.

Purpose of the Study:

  • Investigate the genetic basis of RIRCD and the mechanisms behind its spontaneous recovery.
  • Identify genetic factors contributing to the variable penetrance of the m.14674T>C mutation.

Main Methods:

  • Studied 27 affected and 15 unaffected individuals from 19 families.
  • Performed genetic analysis to identify nuclear gene mutations.
  • Conducted transcriptomic and proteomic analyses on patient muscle tissue.

Main Results:

  • Identified additional heterozygous mutations in nuclear genes EARS2 and TRMU in most affected individuals, but not in healthy carriers, supporting digenic inheritance.
  • Transcriptomic and proteomic data revealed a stepwise metabolic response involving integrated stress response, serine biosynthesis, one-carbon metabolism, and mTOR activation leading to mitochondrial biogenesis.
  • These changes may modulate spontaneous recovery in infants with digenic mutations.

Conclusions:

  • Digenic inheritance involving mitochondrial and nuclear genes plays a crucial role in RIRCD.
  • A stepwise metabolic adaptation, including stress response and mTOR activation, is implicated in disease progression and recovery.
  • Understanding these mechanisms may offer insights into variable penetrance of mitochondrial DNA mutations and potential therapeutic roles for amino acids.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
820
Alterations in Respiration II01:30

Alterations in Respiration II

There are numerous types of normal and abnormal respiration. Based on ventilatory movements, breathing patterns are classified as regular, deep, or shallow. Examples include Biot's breathing, Cheyne-Stokes respiration, Kussmaul's breathing, hyperventilation, and hypoventilation. Each pattern is clinically significant and aids in evaluating patients.
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
1.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
555
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
591
Respiratory Capacities01:24

Respiratory Capacities

Respiratory capacities are crucial indicators of lung function, representing the maximum amount of air an individual's respiratory system can handle during various breathing phases.
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
324